We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

29 hedge funds and large institutions have $17.3M invested in Achieve Life Sciences in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 4

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

81% more funds holding

Funds holding: 16 → 29 (+13)

48% more capital invested

Capital invested by funds: $11.7M → $17.3M (+$5.59M)

5.22% more ownership

Funds ownership: 16.38% → 21.6% (+5.2%)

Holders
29
Holders Change
+13
Holders Change %
+81.25%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
8
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SC
Shay Capital
New York
+$2.55M
2
PCM
Perkins Capital Management
Minnesota
+$1.25M
3
6CM
683 Capital Management
New York
+$1.19M
4
ACM
Altium Capital Management
New York
+$1.16M
5
CC
Clearline Capital
New York
+$1.16M

Top Sellers

1
IC
Ikarian Capital
Texas
-$3.29M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$448K
3
BFM
Boothbay Fund Management
New York
-$387K
4
Citadel Advisors
Citadel Advisors
Florida
-$144K
5
TRCT
Tower Research Capital (TRC)
New York
-$10.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
1
Shay Capital
New York
$3.62M +$2.55M +268,075 +199%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.24M -$448K -47,067 -16%
PCM
3
Perkins Capital Management
Minnesota
$1.54M +$1.25M +131,500 +324%
Morgan Stanley
4
Morgan Stanley
New York
$1.25M +$492K +51,654 +59%
6CM
5
683 Capital Management
New York
$1.12M +$1.19M +125,000 New
ACM
6
Altium Capital Management
New York
$1.1M +$1.16M +122,000 New
CC
7
Clearline Capital
New York
$1.09M +$1.16M +121,812 New
Millennium Management
8
Millennium Management
New York
$916K +$971K +101,986 New
Renaissance Technologies
9
Renaissance Technologies
New York
$691K +$523K +54,899 +249%
LPL Financial
10
LPL Financial
California
$618K +$151K +15,900 +30%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$508K +$261K +27,379 +93%
Two Sigma Investments
12
Two Sigma Investments
New York
$399K +$423K +44,419 New
Two Sigma Advisers
13
Two Sigma Advisers
New York
$388K +$412K +43,255 New
QI
14
QS Investors
New York
$306K +$324K +34,050 New
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$276K +$292K +30,700 New
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$247K +$262K +27,493 New
OC
17
Oppenheimer & Co
New York
$207K +$219K +23,000 New
OQS
18
Occudo Quantitative Strategies
Florida
$171K +$182K +19,082 New
PVI
19
Pura Vida Investments
New York
$153K +$162K +17,000 New
Northern Trust
20
Northern Trust
Illinois
$153K +$163K +17,096 New
State Street
21
State Street
Massachusetts
$133K +$141K +14,761 New
TPA
22
Trivium Point Advisory
Connecticut
$102K +$2.38K +250 +2%
Wells Fargo
23
Wells Fargo
California
$8K +$5.43K +570 +176%
UBS Group
24
UBS Group
Switzerland
$6K +$5.61K +589 New
TRCT
25
Tower Research Capital (TRC)
New York
$3K -$10.2K -1,071 -78%
1
2

ACHV Hedge Fund Activity: Q2 2021 in Review

29 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2021, worth a combined $17.3M — up 48% from $11.7M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new ACHV positions and 4 closed out — a net gain of 13 holders — while 8 added to existing stakes and 3 trimmed.

The largest buyer was Shay Capital, adding an estimated $2.55M. The largest seller was Ikarian Capital, exiting entirely with an estimated $3.29M sold.

  • 29 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2021, up from 16 in Q1 2021.
  • Funds reported $17.3M of Achieve Life Sciences stock for Q2 2021, up 48% quarter-over-quarter.
  • 17 funds opened new Achieve Life Sciences positions in Q2 2021 and 4 closed out, a net change of +13 holders.
  • The largest Achieve Life Sciences buyer in Q2 2021 was Shay Capital, an estimated $2.55M added.
  • The largest Achieve Life Sciences seller in Q2 2021 was Ikarian Capital, an estimated $3.29M sold.

Based on aggregated 13F filings for Q2 2021.